Quick Access

CCR5 Knockout HEK293 Cell Line

CCR5 Knockout HEK293 Cell Line

CCR5 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.

Cat. No EDC07536
Species Human
Cell Line HEK293
Gene CCR5
Size 1×10⁶cells

Product Details

Cat.No. EDC07536 Product Name CCR5 Knockout HEK293 Cell Line
Cell Line HEK293 Cellosaurus ID CVCL_0045
Cell Line Synonyms Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 Gene
NCBI Gene ID Gene Synonyms CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22
Summary
This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]
Associated Diseases Non-tumor
Morphology Adherent Passage Ratio 1/5,2days
Complete Culture Medium DMEM + 10% FBS Freezing Medium 95% Complete culture medium+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.

STR Profile

LociSTR Info (Sample Cell)
Sample Cell Line: HEK293
STR Info (Cell bank)
Cell Line: HEK293
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1P0 12 11 12
D2S1338 19 19
D3S1358 15 17 15 17
D5S818 8 8 9
D7S820 11 12 11 12
D8S1179 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 15 18 15 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11 11
D12S391 19 21 11 15
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying CCR5 (CC chemokine receptor 5, CD195)'s role as the principal HIV co-receptor or modeling its functions in T cell trafficking and HIV-cure strategies. The Knockout line is the standard tool for asking whether CCR5 is required for these processes — CCR5 is a Gαi-coupled seven-transmembrane GPCR activated by CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES), expressed on effector/memory T cells, monocytes, macrophages, and DCs; CCR5 is the principal co-receptor for R5-tropic HIV-1 strains (which represent ~90% of new infections), and the CCR5Δ32 homozygous mutation confers HIV resistance — this is the basis of the Berlin, London, and Düsseldorf patients (cured of HIV by CCR5Δ32 allogeneic HSC transplantation). Overexpression is useful for studying CCR5 in heterologous expression contexts. For HIV research, the EDITGENE CCR5 Knockout in HEK293 is uniquely valuable — HEK293 supports systematic structure-function studies. Rescue with wild-type or signaling-deficient CCR5 enables structure-function studies. The knockout is a critical specificity tool for ⭐⭐ maraviroc (Selzentry, FDA-approved 2007 CCR5 antagonist for HIV-1), leronlimab (PRO 140, anti-CCR5 antibody in development), CCR5-modifying gene therapy approaches for HIV cure (sangamo's SB-728, allogeneic CCR5Δ32 HSCT, CRISPR-based CCR5 disruption), and emerging CCR5-targeted approaches in cancer (CCR5 on Tregs and TAMs).
Yes. CCR5 rescue experiments are well-established for HIV co-receptor research: • Construct design: use a codon-modified CCR5 sequence with a small intracellular C-terminal tag (FLAG, HA). CCR5 is a seven-transmembrane Gαi-coupled GPCR with N-terminal sulfated tyrosines (HIV gp120 binding) — preserve all elements. • Surface localization validation: confirm plasma membrane localization by cell surface staining before HIV envelope binding studies. • CCR5Δ32 rescue: rescue with CCR5Δ32 (frameshift mutation, no surface expression) compared to wild-type recapitulates the HIV-resistant phenotype. • Maraviroc-resistant rescue: gp120-binding-pocket mutations can confer resistance for on-target validation. • Functional readout: rescue should restore R5-tropic HIV envelope-mediated entry and maraviroc sensitivity. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation for HIV research.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Contact Us
*
*
*
How did you hear about us: